Help! What's the term for a zoonotic pathogen like mpox that jumps back and forth from humans to animals? Is it still fair to call mpox a zoonosis? Having a terminology fail. #MicroSky #VirologySky #ImmunologySky

youtube.com/watch?v=hJQU...

#MedSky #IDSky #ImmunologySky #PublicHealthSky

Nucleic-acid-induced ZCCHC3 condensation promotes broad innate immune responses

www.cell.com/molecular-ce... #immunology #innateimmunity #ImmunologySky

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans Nature Immunology - Pulendran and colleagues define a molecular signature that can be used to predict the durability of antibody responses to vaccination and reveal important insights into the...

System vaccinology analysis of predictors and mechanisms of antibody response durability to multiple vaccines in humans

An unexpected role for platelets in modulating antibody response durability.
#medSky #ImmunologySky

www.nature.com/artic...
1/2

Early antiviral CD4+ and CD8+ T cells are associated with upper airway clearance of SARS-CoV-2

Evidence for protective roles for circulating SARS2-specific CD4+ and CD8+ T cells during acute COVID-19. #ImmunologySKy #MedSky

insight.jci.org/arti...
1/2

It's an irony that anti-vax and their claims of wellness and supplements against infectious diseases pass on how vaccines work. Vaccines are among the most natural interventions we use. They select and exercise your own cells! Your cells battle the pathogen better equipped.

#medsky #immunologysky

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase Nature - The development of a first-in-class non-covalent small-molecule inhibitor of SARS-CoV-2 replication that targets the viral guanine-N7 methyltransferase NSP14 is reported.

Small-molecule inhibition of SARS-CoV-2 NSP14 RNA cap methyltransferase

a small molecule that can stop SARS-CoV-2 from replicating in cells. #immunologySky #MedSky

www.nature.com/artic...
1/5

Looking for help from #sciencesky (is that a thing? #immunologysky ?):

If this and the various other vaccines are pulled, what’s the timeline for impacts?

Writing a new NIH grant. Always trying to walk that fine line between what is truly exciting ("I want to do this!") and something mildly boring ("this is feasible"). #GrantWriting #ScienceSky #ChemSky #ImmunologySky